Bioheart, Invitrx sign licensing agreement for adipose derived stem cells – Pharmaceutical Business Review
Bioheart, Invitrx sign licensing agreement for adipose derived stem cellsPharmaceutical Business ReviewInvitrx Therapeutics specializes in the culture and engineering of adult stem cells, new products and therapies that are used in aesthetics, wound closure, and healing, as well as plastic and reconstructive surgery. Since 10 years, Invitrx team has … …read more &nbs… Continue reading
